Aspirin therapy is associated with a lower risk of pregnancy loss in both JAK2‐ and CALR‐mutated essential thrombocythemia—A Mayo Clinic study of 200 pregnancies

Documenti analoghi

• Momelotinib expands the therapeutic armamentarium for myelofibrosis: Impact on hierarchy of treatment choices
  di: Ayalew Tefferi, et al.
  Pubblicazione: (2024)
• New drugs in myelofibrosis: Critical assessment of additional value to monotherapy with JAK inhibitors
  di: Naseema Gangat, et al.
  Pubblicazione: (2024)
• Aspirin use in essential thrombocythemia: Once‐daily or twice‐daily or not at all?
  di: Ayalew Tefferi, et al.
  Pubblicazione: (2024)
• Targeting anemia in myeloid neoplasms
  di: Naseema Gangat, et al.
  Pubblicazione: (2024)
• Therapeutic Targeting of the Activin Receptor Signaling Pathway: Proof of Concept in Myeloid Neoplasms
  di: Ayalew Tefferi, et al.
  Pubblicazione: (2025)